Octreotide in the management of bowel obstruction in terminal ovarian cancer

Gynecologic Oncology

Volumn 61, Issue 3, 1996, Pages 345-348

  Mangili, Giorgia ^a   Franchi, Massimo ^b   Mariani, Andrea ^a   Zanaboni, Flavia ^b   Rabaiotti, Emanuela ^a   Frigerio, Luigi ^a   Bolis, Pier Francesco ^b   Ferrari, Augusto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; METOCLOPRAMIDE; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; VAPREOTIDE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; INTESTINE OBSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; NASOGASTRIC TUBE; OVARY CARCINOMA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TERMINAL DISEASE; VOMITING;

EID: 0029996754     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0154     Document Type: Article

References (26)

1. Beattie, G. J., Leonard, R., and Smyth, J. F. Bowel obstruction in ovarian carcinoma: A retrospective study and review of the literature, J. Palliat. Care 3, 275-280 (1989).
2. Tunca, J. C., Buchler, D. A., Mack, E. A., Ruzicka, F. F., Crowley, J. J., and Carr, W. F. The management of ovarian-cancer-caused bowel obstruction, Gynecol. Oncol. 12, 186-192 (1981).
3. Ripamonti, C. Management of bowel obstruction in patients with advanced terminal cancer, Support Care Oncol. 9, 10-13 (1993).
4. Lund, B., Hansen, M., Lundvall, F., Nielsen, N. C., Sorensen, B. L., and Hansen, H. H. Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy, Surg. Gynecol. Obstet. 169, 213-218 (1989).
5. Rubin, S. C., Hoskins, W. J., Benjamin, I., and Lewis, J. L. Palliative surgery for intestinal obstruction in advanced ovarian cancer, Gynecol. Oncol. 34, 16-19 (1989).
6. Piver, M. S., Barlow, J. J., Lele, S. B., and Frank, A. Survival after ovarian cancer induced intestinal obstruction, Gynecol. Oncol. 13, 44-49 (1982).
7. Krebs, H. B., and Goplerud, D. R. Surgical management of bowel obstruction in advanced ovarian carcinoma, Obstet. Gynecol. 61, 327-330 (1983).
8. Baines, M., Oliver, D. J., and Carter, R. L. Medical management of intestinal obstruction in patient with advanced malignant disease: A clinical and pathological study, Lancet 2, 990-993 (1985).
9. Ripamonti, C. Management of bowel obstruction in advanced cancer, Curr. Opin. Oncol. 6, 351-357 (1994).
10. Reichlin, S. Medical progress: Somatostatin, N. Engl. J. Med. 309, 1495-1501 (1983).
11. Mercadante, S., and Maddaloni, S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients, J. Pain Symptom Manage. 7, 496-498 (1992).
12. Mercadante, S. The use of octreotide in bowel obstruction, Palliat. Med. 7, 78 (1993).
13. FIGO Cancer Committee: Staging announcement, Gynecol. Oncol. 25, 383 (1986).
14. International Federation of Gynecology and Obstetrics. Changes in definition of clinical staging of carcinoma of the cervix and ovary, Am. J. Obstet. Gynecol. 156, 236 (1987).
15. Serov, S. F., Scully, R. E., and Sobin, L. H. Histological typing of ovarian tumors. International Histological classification of tumors, No. 9. World Health Organization, Geneva (1973).
16. Khoo, D., Hall, E., Motson, R., Riley, J., Denman, K., and Waxman, J. Palliation of malignant intestinal obstruction using octreotide, Eur. J. Cancer 30A, 28-30 (1994).
17. Ripamonti, C., De Conno, F., Ventafridda, V., Rossi, B., and Baines, M. J. Management of bowel obstruction in advanced and terminal cancer patients, Ann. Oncol. 4, 15-21 (1993).
18. Pictus, D., Marx, M. V., and Weyman, P. J. Chronic intestinal obstruction: Value of percutaneous gastrostomy tube placement, Am. J. Radiol. 150, 295-297 (1988).
19. Regnard, C., and Comiskey, M. Nausea and vomiting in advanced cancer - A flow diagram, Palliat. Med. 6, 146-151 (1992).
20. Kutz, K., Nuesh, E., and Rosenthaler, J. Pharmacokinetics of SMS 201-995 in healthy subjects, Scand. J. Gastroenterol. 21(Suppl. 119), 65-72 (1986).
21. Mercadante, S., Spoldi, E., Caraceni, A., Maddaloni, S., and Simonetti, M. T. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction, Palliat. Med. 7, 295-299 (1993).
22. Khoo, D., Rilev, G., and Waxman, J. Control of emesis in bowel obstruction in terminally ill patients, Lancet 339, 375-376 (1992).
23. Mercadante, S. Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patient, Palliat. Med. 6, 257-259 (1992).
24. Dean, A., Bridge, D., and Lickiss, J. M. The palliative effects of octreotide in malignant disease, Ann. Acad. Med. Singapore 23(2), 212-215 (1994).
25. Isbister, W. H., Elder, P., and Symons, L. Non-operative management of malignant intestinal obstruction, J. R. Coll. Surg. Edinb. 35, 369-372 (1990).
26. Stiefel, F., and Morant, R. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileum in advanced cancer, Support Care Cancer 1, 57-58 (1993).